Ischemic Preconditioning, Exercise Tolerance and Multiple Sclerosis

CompletedNot a drug-phase studyMS (type not specified)NCT03153553

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Ischemic Preconditioning

Placebo

  • Sham Intervention

What it measured

Main measures

  • Ability to tolerate Ischaemic Preconditioning (IPC_

    One day

    Safety

Other measures (1)

  • Perceived rate of exertion

    One day

    Walking and mobility

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

1. Diagnosis of MS as per the McDonald's criteria 2. Aged 18 or older 3. Sufficient cognitive ability to give informed consent 4. Ability to walk for 6 minutes without rest 5. Resting Systolic BP of less than 170 mmHg

Exclusion criteria

1. Cognitive difficulties in giving consent ad understanding the questionnaire 2. Inability to walk 3. Other systemic illness affecting exercise tolerance 4. Resting systolic BP of 170mmHg or more

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Regular physical activity improves aspects such as physical fitness, fatigue, quality of life, gait and also reduces the rate of progression of disability in individuals with Multiple Sclerosis. However, individuals with multiple sclerosis are less physically active than the general population. The determinants of engaging in physical activity for individuals with multiple sclerosis include psychological factors like motivation, self-belief and self-regulatory constructs and physical factors like fatigue, weakness, pain and ataxia. Ischemic preconditioning is exposure of the body to brief periods of circulatory occlusion and re-perfusion to protect organs against ischemic injury. Recent studies have also shown that ischemic preconditioning also improves exercise performance in healthy participants. The primary aim and objective of this study is to see whether it is feasible to use Ischemic preconditioning to improve exercise performance in people with Multiple Sclerosis. The design for the study is a double blind randomized control trial. Forty patients with multiple sclerosis above 18 years of age and who have the ability to walk will be randomized to receive either Ischemic preconditioning or sham intervention. All participants will be identified by MS consultants and nurses from the MS clinic and Neuro Day Case Unit of the Royal Hallamshire Hospital in Sheffield. Participation will involve an additional 2 hours of the patients time.

Papers

Loading reviews and guidelines…

History

    1. Started

      Apr 2017

    2. Main results due

      Dec 2019

    3. Finished

      Dec 2019

    Assembled by software from public sources.